Streptococcus pneumoniae capsular polysaccharide serotype 7F (Pneumococcal serotype 7F CPS; 7F polysaccharide)

Streptococcus pneumoniae capsular polysaccharide serotype 7F is a major virulence factor and the dominant surface antigen of the pneumococcus bacterium.[1][2] The 7F serotype is notable for being more invasive than many other pneumococcal serotypes and is associated with a higher likelihood of causing invasive pneumococcal disease.[1] The polysaccharide capsule evades host immunity by inhibiting complement activation and reducing opsonization of the bacterium, thereby preventing effective phagocytic clearance.[2] Due to its critical role in virulence and immunogenicity, the 7F capsular polysaccharide serves as a key component of pneumococcal conjugate vaccines, where it is chemically conjugated to carrier proteins such as CRM197 to enhance immune responses.[1][3] The structural complexity of the 7F repeating unit—composed of seven different monosaccharides—presents manufacturing and analytical challenges, but vaccines containing this antigen have been successfully developed and implemented in clinical practice to provide serotype-specific protection against invasive pneumococcal disease.

Other names

Pneumococcal capsular polysaccharide serotype 7F7F capsular polysaccharideStreptococcus pneumoniae type 7F capsuleSerotype 7F CPS

**Vaccine-based mechanisms:** Conjugate vaccination: 7F polysaccharide is conjugated to CRM197 carrier protein to enhance immunogenicity. Antibody induction: Stimulates production of anti-capsular antibodies that promote opsonization and complement-mediated killing. Serotype-specific protection: Antibodies against 7F polysaccharide provide strictly serotype-specific protection against invasive disease. Opsonophagocytic clearance: Enhances host opsonophagocytic mechanisms to clear pneumococci.